BioAdvance commits $2.9M to 15 life sciences companies

Monday, August 1, 2016

BioAdvance announced that during the past 12 months it added nine new companies and technologies to its portfolio and made follow-on investments in six of its existing companies. Overall, these investments represent a $2.9 million commitment to the success and growth of life science companies and to this region.

[Read More]